Introduction: the art and science of switching antipsychotic medications.

From the Department of Psychiatry, Medical College of Georgia, Augusta. The curriculum roundtable “The Art and Science of Switching Antipsychotic Medications” was held January 21, 2006, in Atlanta, Ga., and supported by an educational grant from Bristol-Myers Squibb Company and Otsuka America Pharmaceutical, Inc. Dr. Buckley is a consultant for Abbott, Alamo, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Janssen, Pfizer, and Merck; has received grant/research support from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Janssen, Pfizer, and Solvay; and has received honoraria/expenses from Abbott, Alamo, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Janssen, and Pfizer. Corresponding author and reprints: Peter F. Buckley, M.D., Medical College of Georgia, Department of Psychiatry, 1515 Pope Ave., Augusta, GA 30912 (e-mail: [email protected]). Introduction